Device developer and manufacturer Nemera has announced its acquisition of Insight Product Development, which will become the US office of Nemera's “Insight Innovation Center.” The company's other design center office is located in La Verpillière, France. Insight's capabilities include early stage development of DPIs, MDIs, and connected devices. According to Nemera, … [Read more...] about Nemera acquires Insight Product Development
Products and Services
ISAB gets contract for nebulizer feasibility study
Inhalation Sciences (ISAB) has announced that "a leading European inhaled pharmaceutical developer" has contracted with the company for a feasibility study using ISAB's PreciseInhale aerosol generator with new nebulizer capabilities. The feasibility study is the first to use the nebulizer feature for the PreciseInhale system, which launched in February 2019, the … [Read more...] about ISAB gets contract for nebulizer feasibility study
One Drop to integrate MannKind’s BluHale inhaler monitoring device for Afrezza
The One Drop diabetes management platform has agreed to integrate MannKind’s BluHale inhaler monitoring device for the Afrezza insulin DPI, the companies said. The integration of the BluHale device will allow for monitoring of insulin doses, glucose forecasts, and other services for patients using the Afrezza inhaler. MannKind Corporation CEO Michael Castagna … [Read more...] about One Drop to integrate MannKind’s BluHale inhaler monitoring device for Afrezza
Iconovo announces positive results for ICOres study
DPI developer Iconovo has announced that a PK study of its ICOres reservoir-based inhaler demonstrated that the device delivered a budesonide/formoterol dry powder formulation as expected compared to Symbicort Turbuhaler. According to the company, the clinical study, which enrolled 29 healthy volunteers, showed "slightly higher values for ICOres" related to … [Read more...] about Iconovo announces positive results for ICOres study
Seurat Therapeutics to use Kurve Technology device for intranasal migraine therapy
Kurve Technology has announced that Seurat Therapeutics will use Kurve's intranasal delivery technology for Seurat's IGF-1 nasal aerosol for the treatment and prevention of migraines. Details of the development and collaboration agreement were not disclosed. In October 2018, Seurat announced that it had received a ~$510,000 grant from the National Institute of … [Read more...] about Seurat Therapeutics to use Kurve Technology device for intranasal migraine therapy
Proveris Scientific adds Stephen McDonald to its European support team
Proveris Scientific announced that Stephen McDonald has joined the company's European team, which is based in the UK. McDonald, who has previously worked with Proveris to provide customer support as an independent contractor, will work with European Sales Director Deborah Jones providing customer service support for Europe and the Middle East. McDonald has more … [Read more...] about Proveris Scientific adds Stephen McDonald to its European support team
Aptar acquires Nanopharm and Gateway Analytical
AptarGroup has announced its acquisition of Nanopharm and Gateway Analytical as "part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments." The two companies were acquired by Aptar for a total of approximately $50 million. Both will continue to … [Read more...] about Aptar acquires Nanopharm and Gateway Analytical
Study demonstrates feasibility of inhaled lipid cisplatin delivery via Windtree’s ADS
Windtree Therapeutics and Eleison Pharmaceuticals have announced results from a study that demonstrated the feasibility of delivering Eleison's inhaled lipid cisplatin (ILC) via Windtree's Aerosol Delivery System (ADS). In March 2018, the companies announced that they had partnered for development of ILC for the treatment of lung cancer. According to the … [Read more...] about Study demonstrates feasibility of inhaled lipid cisplatin delivery via Windtree’s ADS
Clement Clarke launches Clip-Tone inhaler feedback device
Clement Clarke has announced the launch of its Clip-Tone technique guidance whistle for use with GSK's Evohaler Ventolin and Seretide MDIs in the UK. The Clip-Tone will be available by prescription only. Like the company's Flo-Tone inhaler training device, the Clip-Tone provides audio feedback when the patient inhales at the correct inhalation rate, with the tone … [Read more...] about Clement Clarke launches Clip-Tone inhaler feedback device
Particle Sciences gets authorization for manufacturing of Schedule I drugs
CDMO Particle Sciences is now registered with the US Drug Enforcement Administration (DEA) as a manufacturer of Schedule I substances, which means that the company can now provide development and manufacturing services for pharmaceutical cannabinoid products. The company points out that it has long been developing and manufacturing Schedule II-V drugs, including … [Read more...] about Particle Sciences gets authorization for manufacturing of Schedule I drugs